VBI Vaccines to Present at the 2015 BIO International Convention
09 juin 2015 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., June 9, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") announced that it will be presenting at the 2015 BIO International Convention on Wednesday, June 17th at 11:30 AM...
VBI Vaccines Presents Data at the World Vaccine Congress Asia That Supports the Potential Use of Its eVLP Platform in the Development of a Novel Hepatitis C Vaccine Candidate
03 juin 2015 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., June 3, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") delivered a presentation, Enveloped Virus-Like Particles: Third-generation VLPs for the Development of a Broadly...
VBI Vaccines to Discuss the Manufacture of Enveloped Virus-Like Particles at the Modern Vaccines Adjuvants & Delivery Systems Conference
15 mai 2015 08h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., May 15, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") will deliver a presentation, Optimization of the Process for Making Clinical Supplies of an Enveloped Virus-like...
VBI Vaccines Announces New Data Supporting the Manufacture of Its Prophylactic CMV Vaccine Candidate
09 avr. 2015 08h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., April 9, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") provided an update on the progress of its cytomegalovirus ("CMV") vaccine development program yesterday at the...
VBI Vaccines Announces Research Collaboration With Sanofi Pasteur to Enhance Vaccine Stability
06 avr. 2015 16h30 HE
|
VBI Vaccines, Inc.
Sanofi Pasteur has chosen VBI's LPV™ technology to develop a more stable formulation of a key Sanofi Pasteur vaccine candidate.
The collaboration will leverage VBI's LPV™...
VBI Vaccines Partners with the Utah CMV Council to Raise CMV Awareness
12 févr. 2015 14h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Feb. 12, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") is pleased to announce its sponsorship support of the Utah CMV Council and the End CMV Silence Gala, a fundraiser...
VBI Vaccines Partners with Le Classique to Raise CMV Awareness in Canada
08 janv. 2015 13h00 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Jan. 8, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") is pleased to announce its sponsorship support of Le Classique, a 3-on-3 ball hockey tournament being held in...
VBI Vaccines to Present at the Noble Financial Capital Markets Equity Conference
06 janv. 2015 16h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Jan. 6, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") will present at the Noble Financial Capital Markets Eleventh Annual Equity Conference on Tuesday, January 20th at...
VBI to Present at the LD Micro Conference
24 nov. 2014 13h30 HE
|
VBI Vaccines, Inc.
Jeff Baxter, VBI's President and CEO, has been invited to speak at the LD Micro Conference in Los Angeles, CA on December 3rd, 2014.
CAMBRIDGE, Mass., Nov. 24, 2014 (GLOBE NEWSWIRE) -- VBI...
VBI Reports Third Quarter 2014 Financial Results and Provides Update on CMV Vaccine Development
14 nov. 2014 16h05 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Nov. 14, 2014 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") has filed operational and financial results for the three- and nine-month periods ended September 30th, 2014 on...